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Summary. Facial palsy is treated by many different oper- 
ative procedures. In addition, factors such as the varying 
degree of paralysis, make postoperative comparisons dif- 
ficult. The limited number of patients treated by free 
muscle transplantation at any one center also compli- 
cates evaluation of alternative treatments. This limita- 
tion has been overcome by development of an Interna- 
tional Muscle Transplant Registry for collection, storage 
and analysis of data from different centers. As of June 1, 
1988, 137 patients from 6 countries have been entered 
into the Registry. Significantly more USA/European pa- 
tients had a congenital deficit and significantly more 
Japanese patients had a deficit resulting from surgery. 
According to a modification of the paresis scoring sys- 
tem proposed by Stennert et al. [3], USA/European pa- 
tients also had a higher degree of nonsurgical facial pare- 
sis than Japanese patients. The most frequent preopera- 
tive treatment used in Japan was electrostimulation in 
24% of cases, only 6% of European and American pa- 
tients received this treatment. Evaluation of surgical pro- 
cedures performed by the 2 groups of surgeons showed 
similar dimensions of muscle grafts used in the face, 
with a length of about 8.5 cm and a width of 3.4 cm. 
The extensor digitorum brevis muscle was the most pop- 
ular, being used in 58% of European and American 
cases, whereas the Japanese choice was the gracilis mus- 
cle in 94% of cases. The length of the nerve graft used 
by Japanese surgeons was 6 cm, longer than that used 
by European and American surgeons. At this time, these 
preliminary data suggest evidence for paresis improve- 
ment in 79% of patients overall. Ultimately, the Registry 
should permit evaluation of the efficacy of different op- 
erative techniques and should influence experimental re- 
search and clinical application of muscle transplanta- 
tion. 
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There is a need for a systematic evaluation of the various 
types of facial muscle transplantation. Since Thompson 
[4] published his first studies using free muscle transplan- 
tation for the treatment of facial palsy in 1971, many 
technical modifications have been initiated. Harii in 1976 
[1] added another variation when he reported the use 
of a free microvascular muscle transplant. Difficulties 
arise in comparing postoperative functional results, even 
when patients have similar deficits. 
The lack of a satisfactory explanation for the variabil- 
ity arises in part from the small number of patients treat- 
ed at any one center. In addition, surgeons have fre- 
quently used a number of modifications of the grafting 
procedure with differences in: 1) numbers of cross-face 
nerve grafts; 2) techniques for nerve repair; 3) mass, 
fiber type, and pennation of donor muscles; 4) sculptur- 
ing of donor muscles; and 5) resting tension placed on 
the graft by sutures. Similarly, during the postoperative 
period grafts may or may not be exposed to the proce- 
dures of debulking, inreasing resting tension by reducing 
graft length, and rehabilitative exercise. No systematic 
studies have been implemented to identify the specific 
contribution of any of these operative or postoperative 
procedures on the degree to which control values of 
structural and functional properties are recovered fol- 
lowing grafting. 
In single center studies, the small number of cases 
handled, coupled with the variability introduced by the 
requirement to adapt operative procedures to individual 
patient needs precludes the identification of the underly- 
ing mechanisms responsible for the excessive variability 
in the function of grafts transplanted into the face. In 
an attempt to resolve the factors that contribute to the 
var iab le  resul ts  r e p o r t e d  for  cross- face  nerve graf ts  and  
free whole  muscle  graf ts  t r a n s p l a n t e d  into  the  face to 
t rea t  un i l a te ra l  facial  para lys i s ,  an  In t e rna t i ona l  Regis t ry  
for  Skeletal  Musc le  T r a n s p l a n t a t i o n  was deve loped  in 
the  D e p a r t m e n t  o f  H u m a n  Genet ics ,  a t  The  Unive r s i ty  
o f  M i c h i g a n  Med ica l  Center  in 1985 and  t r ans fe r red  to 
the  D e p a r t m e n t  o f  Hand- ,  Plas t ic-  and  Recons t ruc t ive  
Surgery ,  Un ive r s i ty  Hosp i t a l ,  Zi i r ich  in 1990. The  under -  
ly ing p h i l o s o p h y  is t ha t  an  u n d e r s t a n d i n g  o f  the b io logy  
o f  whole  musc le  t r a n s p l a n t a t i o n  can  bes t  be achieved 
t h r o u g h  coope ra t i ve  s tudies  in i t i a t ed  by  bas ic  sience and  
cl inical  inves t iga tors .  F u r t h e r m o r e ,  the  submiss ion  o f  
opera t ive  and  p o s t o p e r a t i v e  d a t a  on  the p rocedu re s  used 
and  the results  achieved f rom a n u m b e r  o f  centers  p ro -  
vides the  poss ib i l i ty  o f  a suff icient  d a t a  base  to  resolve 
some o f  the  un reso lved  issues. 
The  eva lua t i on  sys tem for  the  facial  m o t o r  func t ion  
shou ld  be r educed  to a few easily m e a s u r e d  t ra i t s  to  
m a k e  it app l i cab le  to all  pa t i en t s  be ing  assessed by  differ-  
en t  inves t iga tors .  To this end,  a s t anda rd i zed  sys tem for  
the col lect ion,  s to rage  and  analyses  o f  d a t a  f rom pa t ien t s  
wi th  facial  pa l sy  who  have  been  t rea ted  wi th  free muscle  
t r a n s p l a n t a t i o n  has  been  deve loped .  D a t a  are be ing  col- 
lected in a s t a n d a r d i z e d  f o r m a t  f rom six di f ferent  
centers.  This  p a p e r  descr ibes  the  In t e rna t i ona l  Muscle  
T ransp l an t  Regis t ry  ( I M T R )  and  gives a s u m m a r y  for  
pa t ien t s  en te red  as o f  June 1, 1988. The  d iscuss ion  will  
focus on  some genera l  inferences a b o u t  pa t ien ts  who  
have  received free muscle  t r ansp lan t s ,  the  p rocedure s  
used  in the  ope ra t ions ,  the  l imi t a t ion  o f  such an  in te rna-  
t iona l  co l l abora t ive  s tudy,  and  the impl i ca t ions  o f  our  
f inding  for  fu ture  research  and  t r e a t m e n t  o f  facial  palsy.  
Materials and methods 
Data collection instruments 
Surgeons from 6 countries are participating in this study: Austria, 
Japan, Netherlands, Sweden, Switzerland, and the United States; 
this has necessitated the development of standardized data collec- 
tion forms. The content and format of these forms based on the 
experience and recommendations of the participating surgeons and 
other experts in the field of muscle transplantation. The forms 
consist of five different parts: The "General history/physical sum- 
mary", the" Deficit evaluation history", the "Paresis assessment", 
the "Associated physiological abnormalities" and the "Operative 
notes". 
In the "General history and physical summary", the identifica- 
tion code of the patient, age, gender, race, weight at entry into 
the study, and information about family history of facial paralysis 
are recorded. Data on the patient's medical history, such as heart 
disease, high blood pressure, diabetes, malignancy and smoking 
habits are also described. Abnormalities unrelated to the facial 
palsy, which are reported by the patient and by the interviewer, 
are evaluated for the different organ systems. 
The "Deficit evaluation history" records the laterality of the 
deficit, its cause, the time elapsed since the onset, the physical 
change, and the previous treatment. The latter includes the type 
of operation, if any, and any other kind of treatment, e.g., electro- 
stimulation. 
The static and motor functions of the paralyzed side of the face 
were evaluated using a modification of the system proposed by 
Stennert et al. [3]. This scoring system provides the basis for the 
design of the "Paresis assessment" form (Table 1). Recording facts, 
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Table 1. Paresis scoring system for facial palsy adapted from E. 
Stennert, C.M. Limberg and K.P. Fentrup. 4 of the 10 criteria 
(40%) are for the resting score and 6 for the motility score. The 
total number of negative findings equals the paralysis score 









1. Difference between palpebral 
fissures is 3 mm or greater 
2. Ectropion is present 
3. Nasolabial sulcus is absent 
4. Comer of mouth is 3 mm or 
more lower on paralyzed side 
Resting paresis score = sum of 
all true responses from 
questions 1-4 
5. Affected brow motion is 
less than 50% of normal side 
6. Eyelids will not close lightly 
as in sleep 
7. Eyelids will not close tightly 
8. Upon widely showing teeth 
the canine teeth are not visible 
9. Upon widely showing teeth 
the lateral upper incisor 
is not visible 
10. Decrease of distance from 
paretic commissure to philtrum 
when pressing lips is 
less than 50% of that on normal 
side 
Motility paresis score = 
sum of all true responses from 
questions 5-10 
Total paresis score 
the presence of ectropion or of the nasolabial fold, the position 
of the corner of the mouth compared to the healthy side, closure 
of the eyelids, the ability to show different teeth, a simple and 
reproducible method of functional assessment which does not need 
excessive technical instrumentation to implement can be estab- 
lished. This is applicable in daily clinical practice by the different 
investigators. A true response was recorded as a numerical score 
of one and a false response as zero. Finally, a resting paresis score 
(sum of true responses, items 1-4) and a motility paresis score 
(sum of true responses, items 5-10) give a numerical outcome that 
may be used for the comparison of preoperative with postoperative 
evaluations of the same patient and/or comparisons between differ- 
ent groups of patients. Stennert's paresis scoring system was se- 
lected from the different systems proposed in the literature [3]. 
This regional system allows assessment of the differences and 
changes in the various facial regions. In the majority of patients, 
only one region of the paralyzed side of the face is treated by 
muscle transplantation. As with the priority of surgical correction, 
the system used compares rest and motion in different regions 
of the face. It considers the face at rest, weighted at 40% and 
motion, weighted at 60%. The frontalis division is weighted at 
10%, the eye at 40% and the mouth at 50%. 
As associated physiological abnormalities, the presence of the 
corneal reflex and hyperacusis, impairment of gustation, synkine- 
sia, generalized blink reflex, contractures, lacrimation and croco- 
dile tears are assessed. 
One part of the "Operative notes" reports details of cross-face 
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nerve grafting, the second part concerns muscle transplants. Data 
on the number of operations, the number of nerve grafts, the donor 
nerves, the length of grafts, the number of fascicles in the graft 
and in the facial nerve branch, the route of the grafts, the technique 
and quality of nerve repair, and the surgeon who performed the 
nerve graft are included. The muscle grafts are documented in 
a similar fashion. Included is a description of the muscle nerve 
(number of fascicles, distance from nerve suture to muscle), the 
size and mass of muscle in situ and in the grafted site, the donor 
site of the graft, predenervation and the function of the muscle 
which is replaced by the muscle graft. All details of the operative 
technique are entered into the Registry database. For the arterial 
and venous anastomoses, the type of anastomoses, the period of 
ischemia and the number and diameter of vessels repaired are re- 
corded. For the nerve repair between nerve graft and muscle nerve, 
the number of fascicles, the type of repair and the size of the 
sutures used are recorded. If additional procedures are used, e.g., 
reversal of fascial or muscle sling, reversal of tarsorrhaphy or can- 
thoplasty, removal of implants, facial skin excision, these are re- 
corded. 
Protocol for data collection 
The surgeons report data on standardized forms. The forms for 
"General history/physical summary", "Deficit evaluation histo- 
ry", "Paresis assessment" and "Associated physiological abnor- 
malities" are filled out preoperatively. The form" Operative notes" 
is completed postoperatively. Data collection for "Paresis assess- 
ment" and "Associated physiological abnormalities" is repeated 
at each postoperative visit. The postoperative visits are scheduled 
at 6, 12, 18, 24 and 36 months after the last muscle graft operation. 
All data collection forms are sent to the Department of Human 
Genetics at the University of Michigan, Ann Arbor, Michigan, 
USA, for entry into the IMTR database. At the initial data entry, 
a print-out is produced in the format of the data collection forms. 
The resultant print-out for a given patient notes where responses 
are missing from the original data collection form. These print-outs 
are returned to the surgeons to be updated when possible. The 
coordinator of the Registry works with the surgeon to obtain a 
complete data record for the subject. 
Organization of the computer database 
A microcomputer (IBM AT) is used to store, access, and manipu- 
late data in the Registry database. The software has been written 
in dBase III, which facilitates the creation of command files that 
enable the user to easily access data stored in 5 separate dBase III 
databases, each corresponding to one of the data collection forms. 
The dBase III program is menu-driven. By selecting options from 
appropriate menus displayed on the computer screen, one can oper- 
ate particular functions of the software package. Updates to the 
dBase software to accommodate changes in the data collection 
instruments or to improve operative convenience are easily made. 
A special computer program has been developed to keep track 
of the scheduling and collection of the paresis assessments. This 
program builds a database that records the history of paresis assess- 
ments for every patient for each surgeon. It is used to periodically 
generate a report for the surgeon that gives the schedule of assess- 
ments for each patient and notes the completed assessments. 
The computer programs to manage the patient information data- 
base have been installed at two clinics. Eventually, these programs 
will be installed in all participating clinics to enable each collabora- 
tor to manage his own data and provide computerized transmittal 
of data to the IMTR in Ann Arbor. 
Electronic communications system 
In order to facilitate rapid exchange of information across great 
distances, the Bitnet telecommunications system is being used be- 
tween Ann Arbor, Vienna, and Uppsala. All participating surgeons 
have the opportunity to be linked by this system to the data man- 
agement operation in Ann Arbor and to communicate indepen- 
dently between each other. In addition, a telephone accessed Fax 
system is used regularly to facilitate quick mail. 
Results 
Description of patients 
On June 1, 1988, da ta  on  137 pat ients  had  been regis- 
tered with the I M T R .  This sample inc luded 64 males 
ages 6-65 years, and  73 females ages 5-69 years (Fig. 1). 
The sample of  pat ients  inc luded 49 f rom the Un i t ed  
States and  Europe  a nd  88 f rom Japan.  Comple te  infor-  
m a t i o n  abou t  affected side, previous t reatment ,  cause 
of deficit, and  type of  muscle  grafted was available on  
33 U S A / E u r o p e a n  and  79 Japanese patients .  Table 2 
shows that  s ignif icantly more  Japanese males are af- 
fected with facial palsy on  their left sides than  females 
(X 2 = 5.8, Pr  <0.02) .  
Distribution of preoperative clinical variables 
More  than  ha l f  of  the pat ients  (62 of 112) had  no  pre- 
vious t r ea tment  (Table 3). Fo rmer  opera t ions  inc luded 
m a n y  different procedures.  A significantly greater per- 
centage of  the Japanese pat ients  (24%) than  U S A / E u r o -  
pean  pat ients  (6%) had  received e lec t ros t imula t ion  
(X 2 = 37.8, Pr < 0.002). Signif icantly more  U S A / E u r o p e -  
an (39%) than  Japanese pat ients  (15%) had  a congeni ta l  
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Fig. 1. Age distribution at time of muscle graft operation (n = 112) 
Table 2. Laterality of facial palsy by sex of patients (n = 112) 
Affected USA/European Japanese 
side 
Males Females Totals Males Females Totals 
Right 5 10 15 16 28 44 
Le~ 8 10 18 23 12 35 
Total 13 20 33 39 40 79 
Table 3. Distribution of previous treatment (n = 112) European and 
USA surgeons/Japanese surgeons 
First previous treatment Males Females Total 
Electrostimulation 0/11 2/ 8 2/19 
Fascial sling 1/ 0 1/ 0 2/ 0 
Muscle sling 0/ 0 2/ 0 1/ 0 
Eyelid procedures-tarsorrhaphy 2/ 0 2/ 2 4/ 2 
Eyelid procedures-canthoplasty 0/ 1 0/ 0 0/ 1 
Eyelid procedures-implants 0/ 0 0/ 0 0/ 0 
Facelift 0/ 0 0/ 2 0/ 2 
Myotomy on normal side 0/ 0 0/ 0 0/ 0 
Neurotomy or neurectomy 0/ I 0/ 0 0/ 1 
Other procedures a 3/ 6 1/ 6 4/12 
None 7/20 12/22 20/42 
Total 13/39 20/40 33/79 
" Other procedures include: Andersen's operation, hypoglossalfa- 
cia! nerve cross-over, massage, nerve block, medication, acupunc- 
ture, stainless steel sling, cholesteatomectomy 
Table 4. Historic cause of deficit (n= 112) 
Cause of deficit USA/European Japanese Total 
patients patients 
Congenital 13 12 25 
Trauma-extracranial 1 2 3 
Trauma-intracranial 2 2 4 
Bell's palsy 0 15 15 
Poliomyelitis 1 2 3 
Surgical-extracranial 3 26 29 
Surgical-intracranial 3 13 16 
Malignant tumor 1 0 1 
Benign tumor 4 2 6 
Other cause 5 5 10 
Total 33 79 112 
Table 5. Preoperative paresis scores (n = 111) 
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USA/European (n = 33) Japanese (n = 78) 
Males Females All Males Females All 
N = ] 3 20 33 39 39 78 
Resting score 
Average 1.85 1.95 1.91 1.97 1.77 1.87 
S.D. (1.28) (1.00) (1.10) (1.l.4) (0.93) (1.04) 
Motility score 
Average 3.92 3.85 3.88 2.02 2.18 2.10" 
S.D. (2.43) (1.87) (2.07) (1.60) (1.60) (1.59) 
Total paresis score 
Average 5.77 5.80 5,79 4.00 3.95 3.97 a 
Score ( 3 . 1 1 )  (2.48) (2.70) (2.34) (2.16) (2.24) 
" USA/European scores are significantly higher than those of Japa- 
nese at the 0.001 level of probability. Scores may range from 0 
to 10. The larger the score the greater the deficit 
Table 6. Muscle used for transplantation (n = 112) 




Extensor digitorum brevis /9 (0) a 0 (0) 19 
Gracilis muscle 10 (10) 74 (74) 84 
Latissimusdorsi 0 (0) 4 (4) 4 
Palmarislongus 2 (0) 0 (0) 2 
Other b 2 (1) 1 (3[) 3 
33 (11) 79 (79) 112 
" Number of grafts with vascular anastomoses given in ( ) 
b Other: Sartorius, Extensor hallucis brevis, rectus abdominis 
more  Japanese (33%) than  U S A / E u r o p e a n s  (9%), the 
deficit was caused by extracranial  surgery (X 2 -- 7.3, P r  < 
0.01). For  all patients,  the mos t  frequent  cause was ex- 
t racranial  surgery (26%), followed by congenital  (22%), 
intracranial  surgery (14%) and Bell's palsy (13%). Inter- 
estingly, only in Japanese patients was Bell's palsy treat- 
ed by muscle t ransplantat ion.  
Preoperat ive paresis evaluat ions were available on 
111 o f  the l l 2 p a t i e n t s  described in Tables 2-4. Al- 
t hough  the average resting paresis score was very similar 
for  the 2 groups,  U S A / E u r o p e a n  patients had  a signifi- 
cantly greater average moti l i ty  paresis score than Japa-  
nese (Table 5). N o  evidence for a significant association 
between gender and paresis score for  either group o f  
patients was observed. 
Description of operation received 
In fo rmat ion  on vascular  anas tomoses  was available on 
110 o f  the 112 patients considered in this study. 88 o f  
the 110 received a documented  vascular  anastomosis .  
In  83 o f  these 88, re innervat ion o f  the muscle t ransplant  
was by a single cross-face nerve graft. The principal dif- 
ferences were in the muscle transferred for  the 112 pa- 
tients described in Tables 2-4.  In over 90% o f  the Japa-  
nese operat ions  (74 patients), the gracilis was the muscle 
o f  choice (Table 6). Besides the gracilis muscle, the latis- 
simus dorsi was t ransplanted in 4 cases, and the rectus 
abdominis  muscle in I case. In  the 33 U S A / E u r o p e a n  
operations,  the extensor d ig i torum brevis was used 
19 times, and the gracilis muscle 10 times. Other  muscles 
were rarely used;  the palmaris  longus in 2 patients,  the 
sartorius in 1 pat ient  and the extensor hallucis brevis 
in 1 patient. 90 o f  the 112 operat ions  (80%) involved 
vascular  anastomoses.  All Japanese operat ions  and 33% 
o f  the U S A / E u r o p e a n  operat ions  involved revascular- 
ized muscles. 
Measurements  o f  the final size o f  the muscle, or  par t  
o f  a muscle, t ransplanted into the face were no t  available 
on all o f  the 112 patients considered in Tables 2-6. For  
those measured,  no  statistically significant differences 
( P r < 0 . 1 0 )  in the average length or  width o f  the muscle 
for  the 2 groups  (Table 7) was observed. The overall av- 
erage length o f  8 . 5 2 c m  ( S D = 1 . 9 )  and a width o f  
3.32 cm ( S D =  1.4) for  all patients seems to be appro-  
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Table 7. Characteristics of the cross-face nerve graft and the muscle 
transferred 
European and Japanese 
USA surgeons surgeons 
Males Females All Males Females All 
Length of cross-face nerve graft (cm) 
Average 14.66 16.44 /6.00 23.29 21.62 22.28" 
S.D. (1.52) (4.30) (3.81) (3.54) (5.38) (4.77) 
n 3 9 12 17 26 43 
Length of muscle (cm) 
Average 7.00 7.80 7.56 8.72 8.56 8.65 
S.D. (2.64) (3.21) (2.92) (/.89) (1.74) (1.81) 
n 3 7 10 38 33 71 
Width of muscle (cm) 
Average 1.50 3.67 3.02 3.40 3.34 3.37 
S.D. (0.50) (4.31) (4.3/) (0.62) (0.60) (0.60) 
n 3 7 10 35 32 67 
" Average length of nerve used by Japanese surgeons was signifi- 
cantly greater than those used by European and USA surgeons 
at the 0.00l level of probability 
priate for a facial muscle graft. The average length of  
the nerve graft (Table 7) used by the Japanese, 22.28 cm, 
was significantly longer than that used by Europeans 
and Americans, 16.00 cm. No evidence for an associa- 
tion between gender and size of  muscle used or length 
of  nerve graft  was observed for either USA/European  
or Japanese patients. These data suggest that  the rela- 
tionship between length of  muscle nerve and length of  
nerve graft used by the 2 groups was somewhat  different. 
Postoperative improvement of paresis score 
Because the majori ty of  the patients entered into the 
Registry as of  June 1, 1988 provide only retrospective 
data, many  are missing several of  the paresis assessments 
provided by the follow-up protocol.  One or more  assess- 
ments were available on each of  the 112 patients consid- 
ered here. Only a few patients were evaluated at all time 
periods. All but one patient had a preoperat ive paresis 
evaluation. 
The average paresis scores of  those measured during 
each time period are summarized in Fig. 2. Postoperative 
resting scores showed greatest improvement  during the 
first 12 months.  Patients who were evaluated thereafter 
showed little improvement.  On the average, the motility 
score did not improve until 24 months.  These data sug- 
gest that  the early improvement  of  the total paresis score 
is at tr ibutable to improvement  of  resting scores while 
improvement  after two years is attributable to improve-  
ment  of  motility scores. 
Table 8 compares  the average postoperat ive scores 
collected at each time period on subgroups of  the 112 pa- 
tients with their corresponding average score for the pre- 
operative evaluation. In contrast  to the averages based 
on all data presented in Fig. 2, the 30 patients evaluated 
at preop and at 6 months  show a statistically significant 
improvement  in their total score. This was primarily at- 
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Fig. 2. Mean of paresis scores (+standard deviation) for all assess- 
ments at the different time points after free muscle transplantation 
for the treatment of facial palsy. Patients included (n = 72) had 
at least one muscle graft operation, a preoperative paresis assess- 
ment and at least one postoperative paresis assessment 
Table 8. Improvement at specific time points (average at each time 
point minus preoperative average) 
Time n Resting Motility Total 
point 
6 Month 30 --0.23 -0.53"* --0.77* 
12 Month 32 -•.38*** -0.84* -2.22*** 
18 Month 30 -1.53"** -0.67 -2.20*** 
24 Month 32 -1.63"** -1.06"** -2.69*** 
36 Month 14 -1.29"** -1.49" -2.36*** 





tributable to a small improvement  in motility score. 
There was highly statistically significant evidence for im- 
provement  of the total paresis score regardless of  the 
time lag until the postoperat ive evaluation. The analyses 
presented in Table 8 further support  the inference that  
most  of  the improvement  in resting scores occurs in the 
first 12 months  and that  motility scores did not show 
improvement  until 24 months  after the operation. When 
combined into the total score, it is apparent  f rom these 
data that  little improvement  in the patients overall pare- 
sis evaluation occurred after 24 months.  
Discussion 
Patients registered in the I M T R  thus far show no associ- 
ation between age, race and gender or between time of 
the first muscle graft operat ion and whether they were 
USA/European  or Japanese. No explanation was found 
for the observed excess of  male Japanese with partial 
left-sided facial paralysis. Although no evidence was ob- 
served for a significant association between the first pre- 
vious t reatment  and gender, a significantly large number  
of  Japanese patients had electrostimulation. Preopera- 
tive t reatment  depends largely on the specialty treating 
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the patient before surgery and is not  a consequence of 
patient selection by the surgeon. Conservative treatment 
regimes vary considerable, especially in this international 
study. 
Surprisingly, the cause of the palsy in USA/European 
patients was predominantly congenital (39%) whereas 
in Japanese patients it was extracranial surgery (33%). 
Although no significant association was found be- 
tween gender and preoperative paresis scoring for either 
group, significantly greater motility scores were reported 
for USA/European patients. The facial palsies treated 
by muscle transplantation seem to be more pronounced 
in USA/European patients. The lower motility score in 
Japanese patients is caused by a higher incidence of  in- 
complete or partial facial palsies in this group. Patients 
with left-sided involvement have greater motility scores 
than those with right-sided involvement. We have no 
explanation for this observation. 
When patients of each group were considered sepa- 
rately, there was no significant association between the 
type of muscle used as a graft and gender. However, 
there was a highly significant difference between Japa- 
nese surgeons and European and United States surgeons 
in the type of  muscle transferred. Another  important  
difference between the groups of surgeons is the length 
of the cross-face nerve graft. This difference is due to 
different operative techniques and not  the different anat- 
omy of the muscle used. Japanese surgeons used a nerve 
6 cm longer on average than did the European and Unit- 
ed States surgeons. With progress of the study, perhaps 
the optimal operative technique can be formulated. 
Improvements in the paresis score are greatest in the 
first 12 months following transplantation. This is partic- 
ularly apparent in this study for the resting score. Motili- 
ty scores showed greatest improvement beyond 
18 months following the operation. These observations 
suggest that the paresis evaluation instrument is sensitive 
to detection of changes that may be occurring in resting 
and motility performance of patients receiving a facial 
transplant. 
Limitations of the registry 
At the moment,  the majority of  the 137 patients entered 
are retrospective. Consequently, data are incomplete for 
many patients resulting in considerable variability of 
sample size for various types of measurements, especially 
for postoperative evaluations. With time, there will be 
new cases with complete data and a complete three year 
I M T R  follow-up thus meaningful statistics will be pro- 
duced. The cooperation from participating surgeons sug- 
gests that the data collection protocol can be completed 
on a much larger sample of  patients receiving the muscle 
transfer to the face. The complex functional status of 
the face cannot be documented adequately by a 10 point 
scoring system that includes a resting score as well as 
a motility score. Nevertheless, the facial paralysis defect 
score proposed by Stennert et al. [3] combines a compre- 
hensive description of  the static and dynamic function 
of the face with a high practicability in the situation 
of  repeated clinical assessments of the changing function. 
This simple method avoids the necessity of extensive 
technical instrumentation. It can be used by different 
investigators in different geographical locations in an 
easily reproducible way. 
Implications of findings for future research and for 
clinical application 
At this stage of the study, many significant results have 
been obtained. As far as how they apply to the differ- 
ences in operative techniques, experimental research 
could help to eliminate the complexity of relevant factors 
like age of patient, surgeon performing the operation 
and other differences in technical details of the opera- 
tion. For example, the influence of the relationship be- 
tween the length of the cross-face nerve graft and the 
length of  the nerve of the muscle graft on the functional 
recovery of the muscle graft might be clarified in an 
experimental series. Within the current Registry, it is 
not possible to produce a group of patients large and 
homogenous enough to answer this question. 
The experiences with the use of the data collection 
instruments have necessitated several changes. In addi- 
tion, the use of  the standardized video documentation 
has been discussed as an alternative method of measure- 
ment of paresis. In the future, the opinion of the patient 
on the improvement of his facial disability must be inte- 
grated in a more detailed way and without the influence 
of the treating surgeon. In the future, information from 
the International Muscle Transplant Registry database 
can be expected to influence the clinical use of  muscle 
grafts for the treatment of facial palsy. For the present, 
although analysis of incomplete retrospective data sug- 
gests some interesting trends; strong inference with re- 
gard to a number of key issues must await an expanded 
dataset that includes complete prospective data on a re- 
presentative subset of patients. 
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Editorial comment 
Facial palsy is a frustrating entity to treat. Each surgeon 
has his "pet"  method; the justification for its use is 
usually anecdotal and frequently inaccurate. It is disap- 
pointing to see presentations which rely on enthusiastic 
presentation and still photographs. Only by animation 
provided by video can a true assessment of results be 
made. Dr. Frey and his colleagues are to be congratulat- 
ed on many aspects of their presentation. They realize 
the importance of a prospective investigation but have 
based the design on an extensive retrospective series. 
The investigation is international, standardized and well 
controlled. They recognize the deficiencies of static dis- 
plays and are investigating the use of video. Perhaps 
most important, they are, at least initially, limiting the 
investigation to muscle transplantation. 
Perhaps to enable significant results to be obtained 
more expeditiously, other centers dealing with large 
numbers of patients should be invited to join in this 
Registry. 
Ian T. Jackson, Editor-in-Chief 
THE S E A R C H  B O A R D  
It has  been dec ided  to create  a new sect ion in the Journal for  adver t i sements .  This is i n t ended  
to be an  i n f o r m a t i o n  source  abou t  plastic surgery  fel lowships which  are available, or  being 
created,  a n d  as m u c h  i n f o r m a t i o n  abou t  these fellowships as the d i rec tor  o f  the p r o g r a m  wou ld  
wish to insert.  In add i t ion  to this, news o f  any  o the r  posi t ions available, pract ices  for  sale, 
or  pa r tne rsh ips  avai lable  wou ld  be welcomed.  
The  service is free o f  charge ;  all i n f o r m a t i o n  to be publ i shed  should  be sent  to the Edi tor .  
